Articles related to Covid -19 associated with Pregnancy
Successful outcome of severe COVID-19 in pregnancy: individualised approach
Authors: Anupama Dave ,1 Priyansha Joshi,1 Sunil Jaiswal,2 Pradnya Kapdeo1
Review of care and management of pregnant women during COVID-19 pandemic.
Title: Coronavirus disease-19 (COVID-19) is caused by severe acute respiratory syndrome coronavirus-2 (SARSCoV-2). Covid-19 pandemic began in the end of 2019 and spread all over the world in a short duration of time. Measures have been taken such as social distancing, compulsory lockdown and restriction of activities so as to prevent spread of virus. It has posed problem to both the antenatal women and maternity care workers. The care and management of pregnant women is an essential service to identify high-risk mothers and also to have good pregnancy outcome for both mother and baby. Any delay in this may lead to catastrophe, hence this issue needs to be addressed properly. This review briefs about the literature available on antenatal care during covid-19 pandemic. Pregnancy is not very adversely affected by the virus itself but extra caution should be taken to prevent and complications should they arise. The norms of social distancing by patients and wearing personal protective equipment by hospital staff, testing of pregnant women should be followed as per regional and national guidelines. This will help ensure safety of all people along with care to the expecting mother. The presence of covid-19 infection should not deter women from receiving antenatal care nor should the obstetric treatment be delayed during labor. Decision for timing and mode of delivery should be individualised based on obstetric indications and maternalefetal status. © 2020 Taiwan Association of Obstetrics & Gynecology. Publishing services by Elsevier B.V. This is an open access article under the CC BY-NC-ND license .
COVID-19-related anxiety and concerns expressed by pregnant and postpartum women—a survey among obstetricians.
Authors: Madhuri H. Nanjundaswamy1 & Lakshmi Shiva1 & Geetha Desai1 & Sundarnag Ganjekar1 & Thomas Kishore2 & Uma Ram3 & Veena Satyanarayana2 & Harish Thippeswamy1 & Prabha S. Chandra
COVID-19 Pandemic and Pregnancy in Kidney Disease.
Authors: Divya Bajpai and Silvi Shah
Maternal and perinatal outcomes in pregnant women infected by SARS-CoV-2: A meta-analysis
Authors: Ioannis Bellosa , Aakash Panditab, *, Raffaella Panzac
Diagnosis and principles of management of gestational diabetes mellitus in the prevailing COVID-19 pandemic.
Authors: Veeraswamy Seshiah & Vijayam Balaji & Samar Banerjee & Rakesh Sahay & Hema Divakar & Rajesh Jain & Rajeev Chawla & Ashok Kumar Das & Sunil Gupta8 & Dharani Krishnan
Abstract : Limited medical facilities are available due to Covid-19 pandemic. Nevertheless, all efforts should be made in planning judicial and possible methods of delivering health care, particularly to pregnant woman with GDM. GDM may play a crucial role in the increasing prevalence of diabetes and obesity and also may be the origin of cardiometabolic diseases. Methods It is mandatary to diagnose and care pregnant woman with GDM. The test suggested to diagnose GDM has to be evidence based and in this regard “a single test procedure” evaluated meets this requirement. This doable test has been accepted by the Diabetes in Pregnancy Study Group India (DIPSI) and approved by MHFW-GOI, WHO, International Diabetes Federation, and International Federation of Obstetricians and Gynecologists. MHFW-GOI also recommends testing at first antenatal visit and then at 24–28 weeks of gestation. This opportunity can also be utilized for performing ultrasonography for assessing fetal development. Result The first-line management is MNT and life style modifications. Non-responders may require insulin or OHA. The target glycemic control is FPG ~ 5.0 mmol/dl (90 mg/dl) and 2 h PPPG ~ 6.7 mmol/dl (120 mg/dl). The goal is to obtain newborns birth weight appropriate for gestational age between 2.5 and 3.5 kg, a step to prevent offspring developing diabetes. Conclusion The essential precaution required during COVID pandemic is to wear face mask, avoid crowded places, and maintain social distancing. Finally, the economical and evidence based “single test procedure” of DIPSI is most appropriate for screening during the COVID pandemic.
Breast Feeding in Suspected or Confrmed Cases of COVID 19–a New Perspective.
Author: R. Hethyshi
Abstract The encounter with the rampant novel Corona virus infection has led the healthcare system across the world to update and modify its tools to fght this pandemic. Pregnancy, childbirth and breast feeding are a set of special situations to be dealt in women aficted with Covid-19. Currently there is no universal consensus on managing the issue of breast feeding with rooming-in of the neonates in women with suspected or confrmed Covid-19. Literature is still evolving with contradictory guidelines from various authorities across the globe. This review intends to analyse the available evidence on managing breast feeding in such women and to derive a practically plausible approach in handling such situations.
Impact of the Coronavirus Infection in Pregnancy: A Preliminary Study of 141 Patients
Authors: Arun Harishchandra Nayak1 · Deepali Swapnil Kapote1 · Michelle Fonseca1 · Niranjan Chavan2 · Rahul Mayekar2 · Meenal Sarmalkar2 · Amarjeet Bawa2
The novel coronavirus disease (COVID-19) is the most challenging health crisis that we are facing today. Against the backdrop of this pandemic, it becomes imperative to study the efects of this infection on pregnancy and its outcome. Hence, the present study was undertaken to evaluate the efects of COVID-19 infection on the maternal morbidity and mortality, the course of labour as well as the neonatal outcome. Materials and Methods A total of 977 pregnant women were included in the study, from 1st April to 15th May 2020 at a tertiary care hospital. There were 141 women who tested COVID positive and remaining 836 patients were included in the COVID negative group. Findings were compared in both the groups. Results The incidence of COVID positive pregnant women was found to be 14.43%. More patients delivered by LSCS in the COVID positive and the COVID negative group (50%) as compared to COVID negative group (47%), (p>0.05). Low APGAR score (0-3) was observed in 2(1.52%) neonates of COVID positive mothers and in 15 (1.91%) neonates of COVID negative mothers. Overall most of the babies were healthy. Out of all babies tested, 3 were detected positive initially which were retested on day 5 and were found to be negative. Conclusion There is no signifcant efect of COVID infection on maternal and foetal outcome in pregnancy and there is no evidence of vertical transmission of the COVID-19 infection but long-term follow-up of these babies is recommended.